Teladoc Health - AI Stock Analysis

Analysis generated February 24, 2026

Teladoc Health is a leading telemedicine and virtual healthcare company that offers online medical consultations by connecting patients with healthcare professionals via phone and video calls. The company provides a range of services including remote primary care, mental health care, dermatology, and specialist services. Its goal is to provide accessible and cost-effective healthcare solutions. Given the growing trend of digital health and the increased acceptance of telemedicine, Teladoc Health has been positioned as a key player in this rapidly expanding market. However, recent performance metrics suggest caution in evaluating the stock's potential.

Fundamental Analysis

Teladoc Health's revenue for the last quarter was $626 million. This represents a decrease of 0.86% compared to the quarter before it, indicating a need for concern about the company's short-term revenue generation capabilities. Moreover, compared to the same quarter last year, there is a decrease of 2.20%, which further raises concerns about potential longer-term issues with revenue growth.

The net income for the last quarter was $50 million, showing a significant decrease of 51.58% compared to the previous quarter and a decline of 48.78% when compared to the same quarter last year. This alarming decline in profitability is a major point of concern.

EBITDA for the last quarter was $35 million, which represents a massive decrease of 1,415.21% compared to the quarter before it and a decline of 362.73% compared to the same quarter last year. These severe drops indicate potential operational challenges and financial health issues.

Adding to the concerns are insider activities, as recent months have seen company insiders sell their stock, potentially a bearish signal indicating a lack of confidence in the company's near-term performance.

Technical Analysis

Teladoc Health's current stock price is $4.50, reflecting a decrease of 28.91% compared to a month ago, and a decrease of 59.75% compared to a year ago. This downward trend is concerning for both short-term and long-term investors.

The trend is clearly bearish, with the current SMA10 at 4.67, lower than the previous SMA10 of 4.68, suggesting continued downward price movement. The RSI of 15.5 indicates the stock is potentially oversold, which could present a buying opportunity if other conditions were favorable.

Alternative Data Analysis

Evaluating job postings and employee sentiment, Teladoc Health has 57 open positions, and this number has remained stable, indicating a steady staff requirement. However, employee sentiment is low, with only 32% having a positive outlook on the business, and this is down by 6% over the last few months, which is a worrying trend.

Customer acquisition data shows positive signals, with an estimated 1.7 million visitors to their webpage, up by 85% in recent months. Furthermore, daily mobile app downloads stand at 3,300, up by 25%, both bullish trends indicating potential customer growth.

Customer engagement metrics present mixed signals: Instagram followers are up by 11% to a total of 16,000, indicating increasing interest, but Twitter followers remain stagnant at 18,000, suggesting that their social media reach could be improved.

Additionally, according to AltIndex's AI score considering fundamental, technical, and alternative data, Teladoc Health has a score of 57, which is a hold signal.

Conclusion and Recommendation

Teladoc Health is facing a challenging period with declining revenues, net income, and EBITDA metrics pointing to significant financial pressures. Technical indicators highlight a bearish trend, although the very low RSI suggests potential for an oversold rebound. Alternative data provides a mixed picture with positive customer acquisition trends but concerning employee sentiment. On balance, Teladoc Health presents a complex investment proposition with notable risks. Therefore, given the available data and various analysis metrics, a conservative hold strategy is recommended until more positive signs of stability and growth emerge.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.